Cure.’s Post

Shawn Kwatra, MD, Naiem Issa, MD, PhD, and Jennifer Hsiao, MD discuss how advancements in treatment strategies and diagnostic techniques can optimize the management of Chronic Spontaneous Urticaria (CSU), with the goal of improving patient outcomes and enhancing quality of life. Watch now: bit.ly/4frPpbE

Theresa LaBranche, MS PA-C, MBA, CEO of Front Door Medspa, shares how today's patients are highly educated and eager to explore regenerative medicine. Learn how patient education and commitment to long-term treatment plans can lead to transformative results. Discover why understanding and addressing the root causes of health issues is essential in achieving lasting outcomes. Watch the full video here: https://lnkd.in/e5C8M-Xj #RegenerativeMedicine #PatientEducation #HealthcareInnovation

Great news for #thyroid treatment! A 10-year study confirms that radiofrequency ablation (#RFA) is a safe and effective option for benign thyroid nodules, achieving a 94% volume reduction with minimal complications. Regular follow-ups are important to monitor any potential regrowth. This retrospective study was approved by the Institutional Review Board of Asan Medical Center (AMC) led by Prof. Jung Hwan Baek. DOI: 10.1089/thy.2024.0082 For more detailed news from Radiofrequency Ablation Proven Effective in Treating Thyroid Nodules | HEALTH | ASAN MEDICAL CENTER NEWSROOM (amc.seoul.kr) #ThyroidHealth #RFA #MedicalResearch #LongTermResults #ThyroidRFA

We have taken a significant step towards preventing the long-term health impact of heart attacks. In 2022, we started working with Acticor Biotech on the LIBERATE clinical study to evaluate a new drug for heart attacks. Today, we are thrilled to announce that the first patient has been treated in the study. This breakthrough brings us one step closer to reducing the long-term health complications caused by heart attacks. We are here to support businesses in delivering healthcare innovations through our cutting-edge clinical research sites and robust healthcare ecosystem. To find out more about this clinical trial, follow the link below: https://lnkd.in/e7QnDEUX #HeartAttacks #ClinicalTrial #HealthcareInnovations #Healthcare #Research #industryCollaboration

Exciting findings in #COPD management: High-intensity non-invasive ventilation therapy shows promise in reducing exacerbations and improving outcomes for patients with CHRF. - By Zimmermann M et al. || - Read more at Pneumon Journal - European Publishing DOI: https://lnkd.in/dzNpeFbe

Hope Amidst Crisis: The ALPHA Project's Medical Breakthrough As traditional antibiotics struggle against rising mutated viruses, the ALPHA project's medical chip emerges as a potential solution. This development offers hope in a challenging healthcare landscape, but concerns surrounding unexplained deaths remain. Discover the implications and innovations in modern medicine. #MedicalInnovation #ALPHACorp #AntibioticResistance #HealthcareBreakthrough #LifelineProject #MutatedViruses #FutureOfMedicine #PublicHealth #MedicalResearch #HopeInHealthcare

Big news in lung health! Ekaterina Pesheva, M.A., in collaboration with Harvard Medical School, unveils a pivotal step towards more accurate and equitable lung function testing. 🌬️ This breakthrough means tests that better reflect diverse populations, ensuring everyone receives the right diagnosis and care. It's a win for medical equity and accuracy! Want to know how this impacts healthcare? Dive into the details and share your thoughts! 👇 🔗 Read more here: https://lnkd.in/edyxGfu6 #LungHealth #MedicalInnovation #HealthEquity

Join myself and Genova Diagnostics on Thursday 28th November between 12-1pm (GMT) for this in depth webinar discussing the functional and integrative approach to managing Endometriosis and a review of a complex case from my clinic . Just go to https://lnkd.in/ei_CN4-W Hope to see you there! #webinar #endometriosis #hormonehealth #functionalmedicine #hormonehealth #womenshealth

With advances in diagnostics, modern clinical laboratories can detect the rarest of diseases as well as increasingly common lifestyle conditions accurately and early, paving the way for life-saving interventions. To explore the potential of advanced screening tools and understand the implications for clinical labs, read the full story right here: https://lnkd.in/e3sGb3Km #Roche | #ValueOfDiagnostics | #LabProfessionalsWeek | #LabWeek | #LabIsEverything

In the landmark TRAILBLAZER-ALZ 6 Phase 3b study, a simple change in donanemab titration lowered ARIA-E in early Alzheimer’s patients. Could this redefine the standard of care? Dive into the details of this pivotal research. #ClinicalTrials #HealthcareInnovation